עקוב אחר
Dr. Kylie Ainslie
Dr. Kylie Ainslie
Dutch National Institute for Public Health and the Environment (RIVM)
כתובת אימייל מאומתת בדומיין rivm.nl
כותרת
צוטט על ידי
צוטט על ידי
שנה
Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand‏
NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ...‏
Imperial College London, 2020‏
49652020
Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe‏
S Flaxman, S Mishra, A Gandy, HJT Unwin, TA Mellan, H Coupland, ...‏
Nature 584 (7820), 257-261, 2020‏
39802020
The impact of COVID-19 and strategies for mitigation and suppression in low-and middle-income countries‏
PGT Walker, C Whittaker, OJ Watson, M Baguelin, P Winskill, A Hamlet, ...‏
Science 369 (6502), 413-422, 2020‏
9182020
Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study‏
AB Hogan, BL Jewell, E Sherrard-Smith, JF Vesga, OJ Watson, ...‏
The Lancet global health 8 (9), e1132-e1141, 2020‏
8172020
The global impact of COVID-19 and strategies for mitigation and suppression‏
PGT Walker, C Whittaker, O Watson, M Baguelin, KEC Ainslie, S Bhatia, ...‏
Imperial College London 26, 1-19, 2020‏
6892020
Reduction in mobility and COVID-19 transmission‏
P Nouvellet, S Bhatia, A Cori, KEC Ainslie, M Baguelin, S Bhatt, ...‏
Nature communications 12 (1), 1-9, 2021‏
5512021
Impact of non-pharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand. Imperial College COVID-19 Response Team‏
NM Ferguson, D Laydon, G Nedjati-Gilani, N Imai, K Ainslie, M Baguelin, ...‏
Imperial College COVID-19 Response Team 20 (10.25561), 77482, 2020‏
3762020
Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study‏
NC Grassly, M Pons-Salort, EPK Parker, PJ White, NM Ferguson, ...‏
The Lancet Infectious Diseases 20 (12), 1381-1389, 2020‏
2032020
Response to COVID-19 in South Korea and implications for lifting stringent interventions‏
A Dighe, L Cattarino, G Cuomo-Dannenburg, J Skarp, N Imai, S Bhatia, ...‏
BMC medicine 18, 1-12, 2020‏
1962020
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemic‏
H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ...‏
Nature communications 12 (1), 905, 2021‏
1862021
State-level tracking of COVID-19 in the United States‏
HJT Unwin, S Mishra, VC Bradley, A Gandy, TA Mellan, H Coupland, ...‏
Nature communications 11 (1), 6189, 2020‏
1712020
Evidence of initial success for China exiting COVID-19 social distancing policy after achieving containment‏
KEC Ainslie, CE Walters, H Fu, S Bhatia, H Wang, X Xi, M Baguelin, ...‏
Wellcome Open Research 5, 2020‏
1482020
Declining prevalence of antibody positivity to SARS-CoV-2: a community study of 365,000 adults‏
H Ward, G Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ...‏
MedRxiv, 2020.10. 26.20219725, 2020‏
1412020
Report 21: Estimating COVID-19 cases and reproduction number in Brazil‏
TA Mellan, HH Hoeltgebaum, S Mishra, C Whittaker, RP Schnekenberg, ...‏
1412020
Antibody prevalence for SARS-CoV-2 in England following first peak of the pandemic: REACT2 study in 100,000 adults‏
H Ward, CJ Atchison, M Whitaker, KEC Ainslie, J Elliott, LC Okell, R Redd, ...‏
1362020
Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant‏
P Elliott, D Haw, H Wang, O Eales, CE Walters, KEC Ainslie, C Atchison, ...‏
Science 374 (6574), eabl9551, 2021‏
1162021
Resurgence of SARS-CoV-2: detection by community viral surveillance‏
S Riley, KEC Ainslie, O Eales, CE Walters, H Wang, C Atchison, ...‏
Science 372 (6545), 990-995, 2021‏
972021
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults‏
H Ward, GS Cooke, C Atchison, M Whitaker, J Elliott, M Moshe, JC Brown, ...‏
The Lancet Regional Health–Europe 4, 2021‏
812021
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B. 1.617. 2), the Netherlands, August to September 2021‏
B de Gier, S Andeweg, JA Backer, SJM Hahné, S van den Hof, ...‏
Eurosurveillance 26 (44), 2100977, 2021‏
772021
Antibody prevalence for SARS-CoV-2 following the peak of the pandemic in England: REACT2 study in 100,000 adults‏
H Ward, C Atchison, M Whitaker, KEC Ainslie, J Elliott, L Okell, R Redd, ...‏
MedRxiv, 2020.08. 12.20173690, 2020‏
772020
המערכת אינה יכולה לבצע את הפעולה כעת. נסה שוב מאוחר יותר.
מאמרים 1–20